All PlansCoverageMedium impact
Spinal Cord and Dorsal Root Ganglion Stimulation
Blue Cross & Blue Shield of Mississippi·MS · Pain Management, Neurosurgery, Orthopedics +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
This is a comprehensive medical policy defining coverage criteria and FDA-approved devices for spinal cord stimulation and dorsal root ganglion stimulation procedures. The policy establishes clinical guidelines for these pain management treatments but does not appear to introduce new billing changes or requirements.
Action Required
Review policy A.7.01.25 for spinal cord and dorsal root ganglion stimulation coverage criteria. Billing team should ensure documentation aligns with established clinical guidelines for chronic pain conditions including failed back surgery syndrome, CRPS, and diabetic neuropathy. Verify FDA-approved device lists match current inventory and billing practices.